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Risk factors for developing 
epilepsy after neonatal 
seizures
ABSTRACT
Neonatal seizures are the most frequent neurological disorder in the neonatal period. The incidence is reported to be higher 
than at any other period in life. Because of the unique nature of neonatal brain anatomy, connections and the paradoxical 
nature of neurotransmitters, seizures in this age group vary in semiology from those in older children. They may cause 
irreversible changes to the synapses in the immature brain and progress to epilepsy. 
The aim of the study was to analyse laboratory, clinical, neurophysiological and neuroimaging risk factors for epilepsy in a 
group of children who experienced seizures in the neonatal period.
A retrospective study of 176 newborns admitted to the Department of Neonatology, University Children’s Hospital Ljubljana, 
due to seizures, was performed. Metabolic disorders and hypoxic-ischaemic encephalopathy were the most frequent aeti-
ological factors associated with seizures. Epilepsy rate in the group was 18%. Pathological cardiotocography, reanimation 
after delivery, myoclonic type of seizures, more than one type of seizures, severely abnormal electroencephalography, 
abnormal neurological examination and neuroimaging, treatment with more than one antiepileptic drug and duration of 
treatment more than one month constituted statistically significant independent predictive factors for epilepsy (p< 0.05).
The results of our study further elucidate risk factors for epilepsy after neonatal seizures.
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Introduction
Seizures are the most common clinical 
manifestation of neurological dysfunction 
in newborns. They usually reflect a 
serious underlying condition such as 
hypoxic-ischaemic encephalopathy, 
stroke, haemorrhage, acute infection, 
hypoglycaemia or other metabolic 
disorder or brain malformations. (1)  The 
estimated incidence of neonatal seizures 
is 2 - 3 per 1000 term newborns and 10 
- 15 per 1000 preterm newborns. (2) The 
accumulating experimental data from 
animal studies suggest that seizures may 
lead to persistent neurological sequel by 
interfering with the proper construction 
of cortical neuronal networks. (3,4) 
Although mortality rates have been 
reduced, the morbidity rate remains 
high, with epilepsy being a frequent 
sequel. In addition, the development 
of epilepsy is strongly associated with 
other permanent neurologic disorders 
such as intellectual disability and 
cerebral palsy. (5-7) The occurrence of 
epilepsy after neonatal seizures varies 
in frequency, as reported in previous 
studies, from 3.5% to 56%. (2,8,9)
Clinical studies suggest that the aeti-
ology of neonatal seizures is the most 
important factor influencing the outcome. 
(9) Other prognostic factors reported in 
the literature are interictal electroencep-
halographic features and early onset of 
seizures. (10,11) Establishing the risk 
factors that predict the development of 
epilepsy would allow clinicians to identify 
children at high risk and to plan long-
term follow-up and health assistance. 
The aim of this study was to analyse 
clinical, laboratory, neurophysiologi-
cal and neuroimaging risk factors for 
epilepsy in a group of children with 
neonatal seizures.
Patients and Methods
The retrospective study included 
newborns admitted to the Neonatal 
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Department, University Children’s 
Hospital, Ljubljana, Slovenia, between 
1 January 1999 and 31 December 
2009 due to neonatal  seizures. 
Inclusion criteria were: clinical and/
or neurophysiological seizures in the 
neonatal period (i.e., first 28 days of 
life) and at least two years of follow up 
in our hospital.
The diagnosis of neonatal seizures was 
based on direct observation of clinical 
and/or electroencephalography (EEG) 
events. Seizure types were categorized 
according to Volpe’s classification as 
subtle, clonic, tonic and myoclonic. 
(1) Apnoea spells were considered as 
subtle seizures when concomitantly 
accompanied by other paroxysmal 
events and/or tachycardia.  The time 
of occurrence of the seizures was 
categorized with respect to the age at 
onset: in the first 24 hours, between 24 
and 72 hours and after 72 hours of life. 
The  ae t io logy  was dete rmined 
through the study of clinical history 
and examination, laboratory tests and 
neuroimaging studies (ultrasound, 
computed tomography (CT) and/or 
magnetic resonance imaging (MRI). 
The interictal background EEG activity 
was graded into four categories 
according to Holmes and Lombroso 
criteria: normal, mildly abnormal, 
moderately abnormal and severely 
abnormal. (11) Computed tomography 
scan or magnetic resonance was 
considered abnormal when there 
was evidence of hypoxic-ischaemic 
lesions, malformations, migrational 
disorders or alteration in myelination. 
Interictal neurologic evaluation was 
defined as normal, mildly abnormal, 
moderately abnormal or severely 
abnormal according to Amiel-Tison 
criteria. Information on treatment 
with anticonvulsive drugs and on the 
duration of treatment was collected.
Outcome
Children with post neonatal epilepsy 
were found through search of the 
Neurological Department records. 
Postnatal epilepsy was diagnosed if 
the child experienced more than two 
afebrile and unprovoked seizures after 
the neonatal period. 
Statistical analysis
Statistical analysis compared data 
of children with neonatal seizures 
who developed epilepsy and those 
who did not. The analysis of clinical, 
neurophysiological and neuroimaging 
variables was performed by means of 
chi-square test and Fisher’s Exact Test. 
A p-value of <0.05 was considered 
significant. Statistical analysis was 
performed using SPSS version 19.0.
Results 
During the study period, 176 children, 72 
(40.9%) female and 104 male (59.1%), 
with neonatal seizures were identified. 
Their birth weight was from 620 grams 
to 4500 grams, mean 2820 grams; 





Epilepsy Total   p
Gestational age 0.059
Term 94 (89%) 26 (21%) 120
Preterm 47 (90.4%) 5 (9.6%) 52
Apgar score 0.068
  >5/7 97 (84%) 19 (16%) 116
 <5/7 40 (78.5%) 11 (21.5%) 51
Birth weight 0.068
>2500g 103 (79%) 27 (21%) 130
 <2500g 35 (92%) 3 (8%) 38
Perinatal factors
pathological  CTG 28 (69%) 13 (31%) 41 0.002 *
meconium aspiration 27 (82%) 6 (18%) 33 0.739
shock/haemorrhage/rupture 4 (100%) 0 4 0.372
 LGA/IUGR 5 (83.4%) 1 (16.6%) 6 0.193
Measures at birth
no measures at birth 62 (89%) 8 (11%) 70 0.358
 inflation 27 (70%) 11 (30%) 38 0.053
 resuscitation 24 (70%) 10 (30%) 34 0.044 *
 intubation 26 (74%) 9 (26%) 34  
* p < 0.05;  p based on chi-square or Fisher’s exact test 
CTG, cardiotocography; IUGR, intrauterine growth restriction; LGA, large 
for gestational age.
gestational age from 24  to  41  weeks 
(mean 33 weeks ); 52 (29.5%) were 
premature. Thirty-two children (18%) 
developed epilepsy.  Adverse prenatal 
and perinatal events occurred in 115 
(65.3%) patients though the groups of 
children with and without epilepsy were 
significantly different only in regard to 
pathologic cardiotocography (CTG) 
(p=0.002) and resuscitation after birth 
(p=0.044) (table 1). 
The most common aetiological factor 
for seizures was hypoxic ischaemic 
encephalopathy followed by metabolic 
disorders which included transient 
electrolyte disorders, hypoglycaemia 
and inborn errors of metabolism (table 
2); the groups of children with and 
 3www.signavitae.com
without epilepsy were significantly 
different only in regard to the presence 
of metabolic disorders (p=0.028).
Almost half of the infants presented with 
seizures on the first day of life 80 (46 
%)  (table 3). In the majority of children 
clonic (57; 33%) and subtle (55; 
32%) seizures were present, but only 
myoclonic seizures were significantly 
related to epilepsy (p=0.041). A clinical 
picture of more than one type of seizures 
was also highly significantly (p<0.001) 
related to epilepsy (table 3).
Amiel-Tison neonatal neurological 
assessment and EEG background 
activity were both found to be powerful 
predictors of  adverse outcome 
(p<0.001, p=0.001). Normal and mildly 
abnormal EEG background activity 
was associated with a favourable 
outcome in 78 (45%) out of 84 infants 
(48%), whereas 16 (24%) infants with 
moderately and 9 (41%) with severely 
abnormal background EEG activity had 
an adverse outcome (table 4).  Ninety-
nine (56.2%) infants underwent brain 
imaging studies (CT and/or MRI) in the 
neonatal period. Infants with abnormal 
neuroradiology findings were more 
likely to develop postnatal epilepsy 
than those with normal findings (41% 
vs. 5.1%; p<0.001). Only 3 (5.1%) 
infants with normal brain imaging had 
an adverse outcome (table 4).
Seventeen infants (9.6%) with refractory 




































   ≤24 h 63 (78%) 17 (22%) 80 0.575
   24 - 72h 42 (86%) 7 (14%) 49
   72h -  7 days 31 (84%) 6 (16%) 37
Seizure type
      subtle 45 (82%) 10 (18%) 55 0.95
      clonic 47 (76%) 14 (24%) 57 0.828
      myoclonic 44 (74%) 16 (26%) 60 0.041 *
      tonic 23 (74%) 8 (26%) 31 0.242
      undefined 4 (48%) 3 (42%) 7 0.089
      no data 8 (80%) 2 (20%) 10 0.896
   More than one type 32 (65%) 17 (35%) 49
0.000 *
 Duration of seizures 0.000 *
after  neonatal period 32 (75%) 17 (35%) 49
 
* p < 0.05;  p based on chi-square or Fisher’s exact test







normal 19 (100%) 0 19
mildly abnormal 59 (91%) 6 (9%) 65
moderately  abnormal 51 (76%) 16 (24%) 67
severely abnormal 13 (59%) 9 (41%) 22
CT/MRI <0.001*
 normal 55 (94.9%) 3 (5.1%) 58
abnormal 24 (59%) 17 (41%) 41
Neurological assessment <0.001*
normal 11 (100%) 0 11
mildly abnormal 60 (96.7%) 2 (3.3%) 61
moderately  abnormal 56 (79%) 15 (21%) 71
severely abnormal 13 (48%) 14 (52%) 27  
* p < 0.05;  p based on chi-square or Fisher’s exact test
CT, computed tomography; EEG, electroencephalography; MRI, magnetic reso-
nance imaging.
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seizures, who received a combination 
o f  ant iconvu lsant  medicat ions, 
developed epilepsy (p<0.001). The 
incidence of epilepsy among the group 
of infants with duration of therapy up 
to one month, and duration of therapy 




Many studies have demonstrated that 
neonatal seizures are a significant cause 
of death and adverse neurodevelopmen-
tal outcomes, such as cerebral palsy, 
developmental delay and epilepsy. (11) 
The follow up period in our cohort was 
from one to almost ten years and we 
found that 18% of children who expe-
rienced neonatal seizures developed 
epilepsy. The result is similar to previous 
contemporary cohorts that used broad 
clinical and/or electrographic definitions 
for neonatal seizures. On the contrary, 
some studies that included only children 
with seizures confirmed by EEG found 
a lower incidence rate, which reflects 
problems in the definition of neonatal 
seizures as the same epileptic dischar-
ges may not be detectable by surface 
EEG studies. (12,14-16)
Neonatal seizures usually ref lect 
underlying aetiology. The majority of 
seizures in our population were symp-
tomatic, and different factors from a 
broad spectrum of aetiologies were 
identified. Hypoxic-ischaemic encep-
halopathy (HIE) was identified in the 
majority of infants in our group. It has 
also been the leading cause for neo-
natal seizures in previous studies, tho-
ugh the incidence varied, probably as 
a result of inconsistent diagnostic cri-
teria used. (9) However, HIE was not 
associated with an adverse outcome 
and this was also demonstrated in pre-
vious reports, where neonatal seizures 
and the severity of hypoxic-ischaemic 
encephalopathy were independently 
associated with eventual outcome. 
(17,18) Pathologic CTG, reflecting a 
hypoxic ischaemic event, also proved 
to be independently associated with 
epilepsy in our study.  Among other 
aetiological factors for neonatal seizu-
res, metabolic disorders - inborn error 
of metabolism and hypoglycaemia 
- were significantly associated with 
epilepsy.  There are several putati-
ve mechanisms for hypoglycaemia-
induced cellular injury, including 
excitatory neurotoxins active N-methyl-
d-aspartate receptors, increased 
mitochondrial free radical generation 
and initiation of apoptosis and altered 
cerebral energetic characteristics. 
(19)  Authors who have studied 
outcomes associated with neonatal 
hypoglycaemia have reported visual 
impairments and epilepsy, with the 
parietal and occipital lobes being 
affected most severely. (19)
Although the exact prognostic value of 
the presence of specific seizure types 
remains a challenge for the clinician, 
a number of studies converge in 
reporting that patients with other than 
focal seizures have a worse outcome 
compared to those with focal seizures. 
(20,21) Our results support this obser-
vation as myoclonic seizures were sta-
tistically significant for developing epi-
lepsy. We also proved the correlation 
between the myoclonic type of seizures 
and an underlying metabolic aetiology, 
so in our future work, we should further 
elucidate a possible classification of 
epileptic syndrome (Early myoclonic 
epileptic encephalopathy). (22)
The severity and pattern of neuroima-
ging studies are known risk factors for 
neonatal seizures and subsequent epi-
lepsy, and we also showed a clear rela-
tionship between the results of neuroi-
maging studies and epilepsy. This rela-
tionship is the result of preexisting brain 
abnormalities, which lead to seizures 
but there is controversy from animal 
studies regarding whether neural injury 
can cause changes in excitability, suffi-
ciently to result in unprovoked seizures 
beyond the neonatal period. (23)
Neurologic assessment across the stu-
dies is highly predictive for long-term 
outcome. (9) The Amiel-Tison neurologic 
assessment proved to be useful in reco-
gnizing children who have normal deve-
lopment despite different perinatal risk 
factors, and in identifying those children 
who have adverse neurological outco-
mes and delayed developmental perfor-
mance. (24,25) Our study also proved 
the value of this method of assessment 
for identifying children with epilepsy. 
The high predictive value of abnormal 
EEG background activity for outcome 
in neonates with seizures is already 
well known and was also proved in our 
study. (9,10,26) Some other studies 
showed that sequential EEG recordin-
gs have better predictive value; they 
demonstrated that sequential EEG bac-
kground activity was strongly correla-





Anticonvulsive  therapy <0.001 *
     without 10 (83.4%) 2 (16.6%) 12
     Phenobarbital 87 (82%) 19 (18%) 106
     Phenytoin / Phosp-
henytoin 31 (100%) 0 31
      combination 7 (42%) 10 (58%) 17
 Duration of therapy <0.001 *
  < one month 75 (98.7%) 1 (1.3%) 76
  > one month 49 (63%) 29 (37%) 78  
* p < 0.05;  p based on chi-square or Fisher’s exact test
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ted with postnatal death, neurodevelo-
pmental delay and epilepsy. (27)
Despite the low efficacy reported, 
infants with seizures end up being given 
maintenance antiepileptic drugs . The 
duration and need of a combination 
of antiepileptic drugs are indicators of 
clinical severity and are related to an 
unfavourable outcome. In the cohort we 
observed a strong association between 
the need for chronic drug therapy and 
the development of postnatal epilepsy 
was found.
Conclusion 
Epilepsy is an outcome following neo-
natal seizures in the setting of different 
neurologic dysfunctions in the neo-
natal period. Our data provide further 
information for clinicians and parents 
planning long-term care for children 
with neonatal seizures. Children with 
metabolic disorders, those who nee-
ded resuscitation after birth and had a 
pathologic CTG, those with myoclonic 
or more than one type of seizures, and 
those in whom seizures persisted after 
the first month of life and needed trea-
tment after the neonatal period, are at 
a high risk for epilepsy. In the future, 
new neuroprotective and antiepileptic 
agents should be studied in neonates 
with the presented risk factors.
